financetom
Business
financetom
/
Business
/
Acacia Research Q4 Swings to Profit, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Acacia Research Q4 Swings to Profit, Revenue Increases
Mar 14, 2024 2:35 PM

05:03 PM EDT, 03/14/2024 (MT Newswires) -- Acacia Research ( ACTG ) reported Q4 net income Thursday of $0.75 per diluted share, compared with a loss of $0.50 a year ago.

Revenue for the quarter ended Dec.31 was $92.3 million, up from $13.1 million a year earlier.

Analysts polled by Capital IQ expected $8 million.

The company shares were up more than 7% in recent after-hours trading.

Price: 4.27, Change: +0.29, Percent Change: +7.29

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Spotify Adding In-App Messaging Feature
Spotify Adding In-App Messaging Feature
Aug 26, 2025
07:51 AM EDT, 08/26/2025 (MT Newswires) -- Spotify Technology ( SPOT ) said Tuesday it is launching an in-app messaging feature that allows users to start one-on-one conversations and share content directly within the platform. Users can accept or reject message requests, Spotify ( SPOT ) said and added that conversations will be secured with encryption both in transit and...
Regeneron Says Cemdisiran Monotherapy Meets Primary, Key Secondary Endpoints in Late-Stage Trial in Generalized Myasthenia Gravis Patients
Regeneron Says Cemdisiran Monotherapy Meets Primary, Key Secondary Endpoints in Late-Stage Trial in Generalized Myasthenia Gravis Patients
Aug 26, 2025
07:54 AM EDT, 08/26/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Tuesday that its investigational cemdisiran monotherapy met the primary and key secondary endpoints in a late-stage trial in adults with generalized myasthenia gravis. The company said Cemdisiran monotherapy showed a 2.3-point placebo-adjusted improvement in MG-ADL total score. Detailed results from the trial will be presented at an...
Firefly Neuroscience Unveils New 'Clear' Platform; Shares Rise Pre-Bell
Firefly Neuroscience Unveils New 'Clear' Platform; Shares Rise Pre-Bell
Aug 26, 2025
08:30 AM EDT, 08/26/2025 (MT Newswires) -- Firefly Neuroscience ( AIFF ) said Tuesday that it has deployed its new CLeaning EEG ARtifacts platform, also known as Clear, which was developed using Nvidia's ( NVDA ) L40S graphics processing unit. Firefly said the Clear platform uses its proprietary technology to offer electroencephalogram data, which records the brain's electrical activity. The...
Singapore's Keppel files for $53 million claim against Seatrium over Brazil corruption case
Singapore's Keppel files for $53 million claim against Seatrium over Brazil corruption case
Aug 26, 2025
(Reuters) -Singapore's Keppel has initiated arbitration proceedings against local shipbuilder Seatrium for a S$68.4 million ($53.33 million) claim related to a corruption crackdown in Brazil, the companies said on Tuesday. In 2022, Seatrium had made provisions worth S$82.4 million to pay Keppel against claims related to the crackdown, named Operation Car Wash. Seatrium noted the obligation to pay Keppel expired...
Copyright 2023-2026 - www.financetom.com All Rights Reserved